115372 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21249)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)
  7. Center for Hematologic Malignancies (13263)
  8. Hematologic Malignancies, Division of (13087)
  9. Sloan Kettering Institute Postdocs (12936)
  10. Department of Pathology and Laboratory Medicine (12615)
Formats
  1. Journal Article (66747)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (661)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21249)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5599)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115372)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High grade sarcomas with myogenic differentiation harboring hotspot PDGFRB mutations - Opening potential new avenues for targeted therapy
    Meeting Abstract

    Dermawan, J.; Chiang, S.; Hensley, M.; Tap, W.; Antonescu, C.
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Primary cutaneous Ewing sarcoma: An international cohort of a rare entity
    Meeting Abstract

    Parra, O.; Michal, M.; Charville, G.; Kosemehmetoglu, K.; Rosenberg, A.; Diaz-Perez, J.; Chebib, I.; Gonzalez-Krellwitz, L.; Busam, K.; John, I.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Detection of GRM1 gene rearrangements in chondromyxoid fibroma by fluorescent-in-situ hybridization (FISH) - Correlation with RNA sequencing and immunohistochemistry
    Meeting Abstract

    Torrence, D.; Dermawan, J.; Zhang, Y.; Vanderbilt, C.; Mullaney, K.; Jungbluth, A.; Sukhadia, P.; Agaram, N.; Hameed, M.
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Whole-genome sequencing analysis of metaplastic breast cancers shows infrequent homologous recombination deficiency
    Meeting Abstract

    Bhaloo, S.; Gazzo, A.; Da Cruz Paula, A.; da Silva, E. M.; Selenica, P.; Zhu, Y.; Blanco-Heredia, J.; Pei, X.; Patel, J.; Wen, H.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Breast cancers harboring FANCA genetic alterations
    Meeting Abstract

    Cartagena, L. C.; Marra, A.; Brown, D.; Gazzo, A.; Selenica, P.; Dopeso, H.; da Silva, E. M.; Kaur, G.; Ross, D.; Zhang, H.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Distinct genomic alterations in radiation-induced angiosarcoma compared to other radiation-associated sarcoma histologies: Rationale for individualized therapeutic targeting
    Meeting Abstract

    Dermawan, J.; Chi, P.; Tap, W.; Rosenbaum, E.; D'Angelo, S.; Alektiar, K.; Antonescu, C.
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Updated survival, efficacy and safety of adjuvant (adj) atezolizumab (atezo) after neoadjuvant (neoadj) atezo in the phase II LCMC3 study
    Meeting Abstract

    Carbone, D. P.; Waqar, S. N.; Chaft, J.; Kris, M. G.; Johnson, B. E.; Lee, J. M.; Wistuba, I. I.; Kwiatkowski, D.; Bunn, P. A.; Schulze, K.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • NVL-655, a selective anaplastic lymphoma kinase (ALK) inhibitor, in patients with advanced ALK-positive solid tumors: The phase I/II ALKOVE-1 study
    Meeting Abstract

    Johnson, M. L.; Ou, S. H. I.; Felip, E.; Baik, C.; Besse, B.; Mazieres, J.; Camidge, D. R.; Gadgeel, S.; Drilon, A.; Elamin, Y. Y.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Multicenter post-acute sequelae of SARS-CoV-2 infection tissue pathology study from the RECOVER program autopsy cohort: A paradigm for investigating diseases of unclear etiology
    Meeting Abstract

    Casimero, F. V.; Del Boccio, P.; Siciliano, M.; Solomon, I.; Padera, R.; Ghosh, S. K.; Joseph, Y.; Kawakami, R.; Kutys, R.; Richards, T.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Treatment sequencing in the VISION study of tepotinib in patients with METexon 14 (METex14) skipping NSCLC
    Meeting Abstract

    Griesinger, F.; Garassino, M. C.; Felip, E.; Sakai, H.; Le, X.; Veillon, R.; Smit, E. F.; Raskin, J.; Thomas, M.; Ahn, M. J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save